Notice Number: NOT-AR-19-034
Key Dates
Release Date: January 8, 2019
PAR-19-149
Issued by
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Purpose
The purpose of this Notice is to inform potential applicants that the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) will participate, effective immediately, in the Funding Opportunity Announcement (FOA) PAR-19-149, "Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)."
The following sections have been updated to reflect the participation of NIAMS in this Funding Opportunity Announcement.
Part 1. Overview Information
The following information has been added:
Components of Participating Organizations:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Catalog of Federal Domestic (CFDA) Number(s):
93.846
Part 2. Section I. Funding Opportunity Description
Research Objectives:
The following information has been added:
The NIAMS is interested in supporting research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases. For more information regarding specific NIAMS scientific areas/programs and contacts, please visit: https://www.niams.nih.gov/grants-funding/supported-scientific-areas.
Part 2. Section VII. Agency Contacts
The following contacts have been added:
Scientific/Research Contact(s):
Fei Wang, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Tel: (301) 594-5055
Email: wangf@mail.nih.gov
Erik Edgerton
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-594-7760
Email: edgertont@mail.nih.gov
All other aspects of this FOA remain the same.
Inquiries
Please direct all inquiries to:
Fei Wang, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Tel: (301) 594-5055
Email: wangf@mail.nih.gov
and Human Services (HHS)
